Lista de obras -

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

artículo científico publicado en 2017

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

artículo científico publicado en 2017

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

artículo científico publicado en 2010

A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

artículo científico publicado en 2016

Affect recognition and functioning in putatively prodromal individuals.

artículo científico publicado en 2013

Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis

scientific article published on 03 January 2007

Are current labeling terms suitable for people who are at risk of psychosis?

artículo científico publicado en 2017

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

artículo científico publicado en 2015

Back to the future: predicting and reshaping the course of psychotic disorder

artículo científico publicado en 2008

Biomarkers and clinical staging in psychiatry

artículo científico publicado en 2014

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

artículo científico publicado en 2017

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance

scientific article published on 28 November 2018

Clinical trajectories in the ultra-high risk for psychosis population

artículo científico publicado en 2018

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2020

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

artículo científico publicado en 2020

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

artículo científico publicado en 2019

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

artículo científico publicado en 2020

Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?

scientific article published on 19 October 2018

Delayed sleep onset in depressed young people.

artículo científico publicado en 2014

Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study

artículo científico publicado en 2014

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

scientific article published on 26 August 2020

Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?

scientific article published on May 2009

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

artículo científico publicado en 2008

Dr McGorry and colleagues reply.

artículo científico publicado en 2013

Dysregulated Lipid Metabolism Precedes Onset of Psychosis

scientific article published on 25 July 2020

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?

artículo científico publicado en 2013

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

artículo científico publicado en 2016

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

artículo científico publicado en 2014

Emotion recognition in individuals at clinical high-risk for schizophrenia.

artículo científico publicado en 2011

Erratum to: A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

artículo científico publicado en 2017

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

artículo científico publicado en 2018

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls

artículo científico publicado en 2012

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

scientific article published on 06 February 2019

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

scientific article published on 07 May 2019

Global research priorities for youth mental health

scientific article published on 01 February 2020

Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification

artículo científico publicado en 2015

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

artículo científico publicado en 2014

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

scientific article published on 01 January 2022

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis

artículo científico publicado en 2017

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

artículo científico publicado en 2009

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

artículo científico publicado en 2013

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

artículo científico publicado en 2015

Negative Psychosis Prevention Trials-Reply

artículo científico publicado en 2017

Negative and Positive Dimensions of Schizotypal Personality Disorder

artículo científico publicado el 1 de enero de 1997

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2018

Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study.

artículo científico publicado en 2012

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS.

artículo científico publicado en 2018

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

artículo científico publicado en 2018

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.

artículo científico publicado en 2013

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

artículo científico publicado en 2020

Online and social networking interventions for the treatment of depression in young people: a systematic review

artículo científico publicado en 2014

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

artículo científico publicado en 2017

PACE: a specialised service for young people at risk of psychotic disorders.

artículo científico publicado en 2007

PM396. Associations of obsessive–compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness.

artículo científico publicado en 2016

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

scientific article published on 17 June 2020

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

artículo científico publicado en 2017

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis

artículo científico publicado en 2012

Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis

artículo científico

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

artículo científico publicado en 2009

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

artículo científico publicado en 2019

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

artículo científico publicado en 2018

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

artículo científico publicado en 2018

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS.

artículo científico publicado en 2018

Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population.

artículo científico publicado en 2013

Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.

artículo científico

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

artículo científico publicado en 2017

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis

artículo científico publicado en 2012

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

scientific article published on 09 October 2019

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

artículo científico publicado en 2018

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

artículo científico publicado en 2018

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

artículo científico publicado en 2019

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

scientific article published on 21 November 2019

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.

artículo científico publicado en 2016

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.

artículo científico publicado en 2016

Whither the attenuated psychosis syndrome?

artículo científico publicado en 2012

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.

artículo científico publicado en 2014

Lista de obras de

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

Affect recognition and functioning in putatively prodromal individuals.

Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis

Are current labeling terms suitable for people who are at risk of psychosis?

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

Back to the future: predicting and reshaping the course of psychotic disorder

Biomarkers and clinical staging in psychiatry

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance

Clinical trajectories in the ultra-high risk for psychosis population

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?

Delayed sleep onset in depressed young people.

Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

Dr McGorry and colleagues reply.

Dysregulated Lipid Metabolism Precedes Onset of Psychosis

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

Emotion recognition in individuals at clinical high-risk for schizophrenia.

Erratum to: A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

Global research priorities for youth mental health

Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

Negative Psychosis Prevention Trials-Reply

Negative and Positive Dimensions of Schizotypal Personality Disorder

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study.

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS.

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

Online and social networking interventions for the treatment of depression in young people: a systematic review

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

PACE: a specialised service for young people at risk of psychotic disorders.

PM396. Associations of obsessive–compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness.

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis

Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS.

Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population.

Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.

Whither the attenuated psychosis syndrome?

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.